ARV-806, a PROTAC KRAS G12D Degrader, in Patients with KRAS G12D–Mutated Advanced Solid Tumors: Preliminary Phase 1 Results
European Journal of Cancer · 2026-11 · 248 · 117457
DOI: 10.1016/j.ejca.2026.117457 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Y.R. Murciano-Goroff und 18 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Murciano-Goroff, Y., Gandhi, N., Spira, A., Patnaik, A., Hong, D., Garrido-Laguna, I., Sharma, S., Chandana, S., O'Neil, B., Bajor, D., Wu, L., Borad, M., Kim, R., Teh, J., Duperret, E., Gong, J., Zhi, E., Pouliot, G., & LoRusso, P. (2026). ARV-806, a PROTAC KRAS G12D Degrader, in Patients with KRAS G12D–Mutated Advanced Solid Tumors: Preliminary Phase 1 Results. European Journal of Cancer, 248, 117457. https://doi.org/10.1016/j.ejca.2026.117457
Vancouver
Murciano-Goroff Y, Gandhi N, Spira A, Patnaik A, Hong D, Garrido-Laguna I, et al. ARV-806, a PROTAC KRAS G12D Degrader, in Patients with KRAS G12D–Mutated Advanced Solid Tumors: Preliminary Phase 1 Results. European Journal of Cancer. 2026;248:117457. doi:10.1016/j.ejca.2026.117457
BibTeX
@article{MurcianoGoroff2026,
author = {Murciano-Goroff, Y.R. and Gandhi, N.J. and Spira, A.I. and Patnaik, A. and Hong, D.S. and Garrido-Laguna, I. and Sharma, S. and Chandana, S.R. and O'Neil, B. and Bajor, D.L. and Wu, L. and Borad, M.J. and Kim, R.D. and Teh, J. and Duperret, E. and Gong, J. and Zhi, E. and Pouliot, G. and LoRusso, P.},
title = {ARV-806, a PROTAC KRAS G12D Degrader, in Patients with KRAS G12D–Mutated Advanced Solid Tumors: Preliminary Phase 1 Results},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117457},
doi = {10.1016/j.ejca.2026.117457}
}
EUVIMED